CAR T-Cells in Acute Lymphoblastic Leukemia: Current Status and Future Prospects

The currently available treatment for acute lymphoblastic leukemia (ALL) is mainly dependent on the combination of chemotherapy, steroids, and allogeneic stem cell transplantation. However, refractoriness and relapse (R/R) after initial complete remission may reach up to 20% in pediatrics. This perc...

Descripción completa

Detalles Bibliográficos
Autores principales: Almaeen, Abdulrahman H., Abouelkheir, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604728/
https://www.ncbi.nlm.nih.gov/pubmed/37893067
http://dx.doi.org/10.3390/biomedicines11102693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604728/
https://www.ncbi.nlm.nih.gov/pubmed/37893067
http://dx.doi.org/10.3390/biomedicines11102693

Ejemplares similares